$104.25 +0.72 (%) Novartis Shs Sponsored American Deposit Receipt Repr 1 Sh - NYSE

May. 28, 2015 | 04:00 PM

Partner Headlines

  1. Amgen Down After Suicides Kill AstraZeneca Deal

    IBD | May. 26, 2015 | 12:39PM EST
  2. Novartis Reports Two Positive US Phase III Programs in COPD for QVA149, NVA237

    Benzinga | May. 20, 2015 | 11:32AM EST
  3. Glaxo more bullish than Q1

    IBD | May. 6, 2015 | 18:59PM EST
  4. Glaxo Q1 Earnings Miss, But 5-Year Guidance Strong

    IBD | May. 6, 2015 | 12:49PM EST
  5. Akorn Downgraded, Stock Falls On 'Credibility Gap'

    IBD | Apr. 27, 2015 | 11:26AM EST
  6. Novartis EPS beats the Street

    IBD | Apr. 23, 2015 | 18:33PM EST
  7. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 17:44PM EST
  8. AbbVie Beats Q1 Estimates; Novartis, Alexion Mixed

    IBD | Apr. 23, 2015 | 11:46AM EST
  9. Amgen Reports An Upbeat Q1 Earnings

    GuruFocus | Apr. 23, 2015 | 11:36AM EST
  10. Novartis Posts Higher Q1 Profit

    Benzinga | Apr. 23, 2015 | 05:22AM EST
  11. Amgen's Q1 Earnings Paints An Overall Positive Image To Investors

    GuruFocus | Apr. 22, 2015 | 15:46PM EST
  12. Teva Offers $40 Bil For Mylan; Perrigo Rejects Mylan

    IBD | Apr. 21, 2015 | 19:04PM EST
  13. Juno Therapeutics Gets Lift From Cancer Test Results

    IBD | Apr. 21, 2015 | 14:57PM EST
  14. Teva Bids $40 Billion For Mylan, But May Need More

    IBD | Apr. 21, 2015 | 11:35AM EST
  15. In Europe Really Recovering?

    GuruFocus | Apr. 19, 2015 | 18:57PM EST
  16. Amgen's First Drug For Cardiovascular Disease Gets The Green Light

    GuruFocus | Apr. 17, 2015 | 22:41PM EST
  17. It's A Big Weekend For Biotech

    Benzinga | Apr. 17, 2015 | 16:31PM EST
  18. Mylan Scores Final Win In Patent Challenge On Inhalation Drug

    Benzinga | Apr. 17, 2015 | 14:27PM EST
  19. Momenta, Novartis get FDA OK

    IBD | Apr. 16, 2015 | 18:43PM EST
  20. Momenta, Novartis Win FDA Nod For Generic Copaxone

    IBD | Apr. 16, 2015 | 14:39PM EST
  21. Receptos MS Drug Succeeds Against Ulcerative Colitis

    IBD | Apr. 16, 2015 | 10:50AM EST
  22. Biotech IPOs Ignite As Aduro Doubles On First Day

    IBD | Apr. 15, 2015 | 13:57PM EST
  23. Pfizer, Biogen, AbbVie Get Good Drug-Trial News

    IBD | Apr. 15, 2015 | 11:49AM EST
  24. AstraZeneca's Onglyza Ups Risk Of Death, FDA Says

    IBD | Apr. 14, 2015 | 14:37PM EST
  25. Benzinga's M&A Chatter for Wednesday February 25, 2015

    Benzinga | Feb. 25, 2015 | 21:26PM EST
  26. Pharmacyclics hits new high

    IBD | Feb. 25, 2015 | 18:51PM EST
  27. Deutsche Bank On Pharmacyclics: 'We Do Not See Much Upside'

    Benzinga | Feb. 25, 2015 | 17:05PM EST
  28. Biotech Pharmacyclics Spikes On Buyout Rumors

    IBD | Feb. 25, 2015 | 14:31PM EST
  29. United Therapeutics Blood Pressure Drug Spurs Q4 Beat

    IBD | Feb. 24, 2015 | 10:04AM EST
  30. Hot Income Stocks: Who's Growing Dividends The Fastest?

    IBD | Feb. 23, 2015 | 16:49PM EST
  31. Can These Three BioTech Companies Make It Big?

    GuruFocus | Feb. 20, 2015 | 15:22PM EST
  32. Can Veeva Systems' Software Keep Luring Big Pharma?

    IBD | Feb. 17, 2015 | 13:26PM EST
  33. Novartis, Verastem & Cepheid Making Biotech Headlines On Friday

    Benzinga | Feb. 13, 2015 | 15:32PM EST
  34. The Reasons That Make Pfizer A Worthy Hold.

    GuruFocus | Feb. 5, 2015 | 11:19AM EST
  35. Credit Suisse Adds 10 Names To European 'Top Picks'

    Benzinga | Feb. 5, 2015 | 07:48AM EST
  36. Stocks That Battle Cancer Were The Best-Performing Biotechs In January

    Benzinga | Jan. 30, 2015 | 13:03PM EST
  37. Valeant Agrees To Buy Dendreon's Provenge

    IBD | Jan. 30, 2015 | 11:39AM EST
  38. Drugmakers Warn On Dollar

    IBD | Jan. 27, 2015 | 18:47PM EST
  39. Strong Dollar Pins U.S. Corporate Earnings Outlook

    IBD | Jan. 27, 2015 | 18:29PM EST
  40. Drug Firms Report Good Q4, But Outlook Cloudy

    IBD | Jan. 27, 2015 | 18:10PM EST
  41. Strong Dollar Means Flabby Outlook For Some Overseas

    IBD | Jan. 27, 2015 | 13:45PM EST
  42. Bristol, Pfizer, Novartis Forecasts Face FX Pressures

    IBD | Jan. 27, 2015 | 11:57AM EST
  43. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 27, 2015 | 08:13AM EST
  44. Novartis Posts Drop In Q4 Net Profit

    Benzinga | Jan. 27, 2015 | 04:58AM EST
  45. Earnings Scheduled For January 27, 2015

    Benzinga | Jan. 27, 2015 | 04:34AM EST
  46. Lannett Early Q2 Earnings Beat Estimates; Stock Jumps

    IBD | Jan. 26, 2015 | 12:20PM EST
  47. Trio Of Wall Street Firms Up Array BioPharma Price Targets

    Benzinga | Jan. 26, 2015 | 10:05AM EST
  48. Can CAR-T Therapy Live Up To The Biotech IPO Hype?

    IBD | Jan. 26, 2015 | 08:02AM EST
  49. Benzinga's Weekend M&A Chatter

    Benzinga | Jan. 25, 2015 | 18:50PM EST
  50. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
Trading Center